Education

Role of Vascular Endothelial Growth Factor (VEGF) in Endothelial Cell Biology

Thursday, April 17, 2008

Dr. David Briscoe, Associate Professor of Medicine and Pediatrics at the Harvard Medical School and staff member at the Children's Hospital Boston, discusses the general role of vascular endothelial growth factor (VEGF) in endothelial cell biology. Dr. Briscoe also describes the complex interplay between TOR signaling and the actions of VEGF. Finally, speculates on whether down regulation of VEGF accounts for the anti-neoplastic and proteinuric effects of TOR inhibition.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.